3,4-diaminopyridine. A potent new potassium channel blocker
- PMID: 667299
- PMCID: PMC1473482
- DOI: 10.1016/S0006-3495(78)85503-9
3,4-diaminopyridine. A potent new potassium channel blocker
Abstract
3,4-diaminopyridine has been found to act very potently in selectively blocking the potassium channels of squid axon membranes. The apparent dissociation constants for this action are estimated to be 5.8 micron and 0.7 micron for external and internal applications, respectively, the potency being about 50 times higher than that of 4-aminopyridine. The block depends upon the membrane potential, time, and stimulus frequency. 3,4-diaminopyridine shows great promise as a useful tool for the study of membrane ionic channels.
Similar articles
-
Site of action and active form of aminopyridines in squid axon membranes.J Pharmacol Exp Ther. 1983 Jul;226(1):174-9. J Pharmacol Exp Ther. 1983. PMID: 6306223
-
Interactions of aminopyridines with potassium channels of squid axon membranes.Biophys J. 1976 Jan;16(1):77-81. doi: 10.1016/S0006-3495(76)85663-9. Biophys J. 1976. PMID: 1244890 Free PMC article.
-
Proceedings: Effects of 4-aminopyridine on the potassium current in internally perfused giant axons of the squid.J Physiol. 1975 Sep;251(1):60P-62P. J Physiol. 1975. PMID: 1185652 No abstract available.
-
On the voltage-dependent action of tetrodotoxin.Biophys J. 1977 Mar;17(3):275-9. doi: 10.1016/S0006-3495(77)85656-7. Biophys J. 1977. PMID: 843585 Free PMC article.
-
Mechanism of action of propranolol on squid axon membranes.J Pharmacol Exp Ther. 1973 Jan;184(1):155-62. J Pharmacol Exp Ther. 1973. PMID: 4686004 No abstract available.
Cited by
-
Electrophysiological function of the delayed rectifier (IK) in bullfrog sympathetic ganglion neurones.Pflugers Arch. 1989 Mar;413(5):482-6. doi: 10.1007/BF00594177. Pflugers Arch. 1989. PMID: 2787017
-
Internal cesium and the sodium inactivation gate in Myxicola giant axons.Biophys J. 1986 Aug;50(2):231-8. doi: 10.1016/S0006-3495(86)83457-9. Biophys J. 1986. PMID: 2427131 Free PMC article.
-
Population Pharmacokinetics/Pharmacodynamics of 3,4-Diaminopyridine Free Base in Patients With Lambert-Eaton Myasthenia.CPT Pharmacometrics Syst Pharmacol. 2017 Sep;6(9):625-634. doi: 10.1002/psp4.12218. Epub 2017 Jul 24. CPT Pharmacometrics Syst Pharmacol. 2017. PMID: 28623849 Free PMC article. Clinical Trial.
-
3,4-Diaminopyridine in the treatment of congenital (hereditary) myasthenia.J Neurol Neurosurg Psychiatry. 1991 Dec;54(12):1069-72. doi: 10.1136/jnnp.54.12.1069. J Neurol Neurosurg Psychiatry. 1991. PMID: 1783919 Free PMC article. Clinical Trial.
-
Gene, Stem Cell, and Alternative Therapies for SCA 1.Front Mol Neurosci. 2016 Aug 12;9:67. doi: 10.3389/fnmol.2016.00067. eCollection 2016. Front Mol Neurosci. 2016. PMID: 27570504 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources